You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pirarubicin

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Beijing (doxorubicin, epirubicin, pirarubicin)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital, ChineseAMS
Mar 17, 2022

Progression-free Survival, Overall Survival, Toxicity Trial in Beijing (pegylated liposomal doxorubicin, pirarubicin)

Withdrawn
  • Progression-free Survival
  • +2 more
  • pegylated liposomal doxorubicin
  • pirarubicin
  • Beijing, China
    Peking University People's Hospital
May 15, 2020

Hepatocellular Carcinoma Trial (Pirarubicin, Oxaliplatin, Lipiodol)

Withdrawn
  • Hepatocellular Carcinoma
  • Pirarubicin
  • +3 more
  • (no location specified)
Jun 1, 2019

0.5-14 Year Old Children With Nephroblastoma Trial in Shenyang (Vincristine, Oxytetracycline/ Cyclophosphamide, Liposomal

Not yet recruiting
  • 0.5-14 Year Old Children With Nephroblastoma
  • Shenyang, Liaoning, China
    Shenjing Hospital
Mar 25, 2019

Bladder Recurrence, Upper Tract Urothelial Carcinoma, Nephroureterectomy Trial in Beijing (Pirarubicin)

Unknown status
  • Bladder Recurrence
  • +2 more
  • Pirarubicin
  • Beijing, Beijing, China
    Peking University Frist Hospital
Nov 15, 2016

Breast Tumors Trial in China (Pirarubicin, Docetaxel, Cyclophosphamide)

Completed
  • Breast Neoplasms
  • Pirarubicin
  • +2 more
  • Shijiazhuang, Hebei, China
  • +4 more
Nov 22, 2015

Lymphoblastic Leukemia, Acute Trial in Nagoya (Methotrexate, Prednisolone, Dexamethasone)

Unknown status
  • Lymphoblastic Leukemia, Acute
  • Nagoya, Japan
    Department of Hematology, Nagoya University Graduate School of M
Nov 13, 2008